Home › Funds › Sands Capital Alternatives, LLC › IKT

Sands Capital Alternatives, LLC position in IKT

INHIBIKASE THERAPEUTICS INC · Health Care

Sands Capital Alternatives, LLC reported holding 13,018,965 shares of IKT (INHIBIKASE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$26.8M, representing 3.97% of its reported portfolio and ranking #7 among its reported holdings. Sands Capital Alternatives, LLC has disclosed IKT holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)13.02M sh
Reported value held$26.82M
Portfolio Weight3.97%
First reportedQ4 2024
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Sands Capital Alternatives, LLC's IKT position evolved

Sands Capital Alternatives, LLC first disclosed a stake in IKT in Q4 2024 at 10,950,000 shares (US$35.6M). Across 8 filings, Sands Capital Alternatives, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 13,018,965 shares valued at US$26.8M.

Quarter by quarter

QuarterSharesValueChange
Q4 2024 10.95M $35.59M New
Q1 2025 10.95M $23.98M Hold
Q2 2025 10.95M $21.35M Hold
Q3 2025 10.95M $17.74M Hold
Q4 2025 13.02M $26.69M Add
Q1 2026 13.02M $21.87M Hold
Q2 2026 13.02M $26.43M Hold
Q3 2026 13.02M $26.82M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IKT and 13F data

IKT (INHIBIKASE THERAPEUTICS INC) is a Health Care company. 67 other funds we track also report a position in IKT — the largest reported positions include Soleus Capital Management, L.P. (US$22.1M), Trails Edge Capital Partners, LP (US$18.4M), Fairmount Funds Management LLC (US$17.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IKT

All IKT fund holders →

FAQ

How long has Sands Capital Alternatives, LLC held IKT?

Sands Capital Alternatives, LLC has disclosed IKT holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is Sands Capital Alternatives, LLC's current position in IKT?

As of Q3 2026, Sands Capital Alternatives, LLC holds 13.02M shares of IKT (INHIBIKASE THERAPEUTICS INC), valued at $26.82M, representing 3.97% of its reported portfolio and ranking #7.

Has Sands Capital Alternatives, LLC been buying or selling IKT?

In the latest 13F filing (Q3 2026), Sands Capital Alternatives, LLC held unchanged its position in IKT.

Which other funds hold IKT?

Other major institutional holders of IKT include Soleus Capital Management, L.P., Trails Edge Capital Partners, LP, Fairmount Funds Management LLC, among 67 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.